1. Home
  2. XRTX vs IVP Comparison

XRTX vs IVP Comparison

Compare XRTX & IVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XRTX
  • IVP
  • Stock Information
  • Founded
  • XRTX 2011
  • IVP 2020
  • Country
  • XRTX Canada
  • IVP United States
  • Employees
  • XRTX N/A
  • IVP N/A
  • Industry
  • XRTX Pharmaceuticals and Biotechnology
  • IVP Diversified Commercial Services
  • Sector
  • XRTX Health Care
  • IVP Miscellaneous
  • Exchange
  • XRTX Nasdaq
  • IVP Nasdaq
  • Market Cap
  • XRTX 3.0M
  • IVP 3.0M
  • IPO Year
  • XRTX N/A
  • IVP 2023
  • Fundamental
  • Price
  • XRTX $0.82
  • IVP $2.08
  • Analyst Decision
  • XRTX
  • IVP
  • Analyst Count
  • XRTX 0
  • IVP 0
  • Target Price
  • XRTX N/A
  • IVP N/A
  • AVG Volume (30 Days)
  • XRTX 45.7K
  • IVP 139.9K
  • Earning Date
  • XRTX 11-15-2024
  • IVP 04-07-2025
  • Dividend Yield
  • XRTX N/A
  • IVP N/A
  • EPS Growth
  • XRTX N/A
  • IVP N/A
  • EPS
  • XRTX N/A
  • IVP N/A
  • Revenue
  • XRTX N/A
  • IVP $17,054,777.00
  • Revenue This Year
  • XRTX N/A
  • IVP N/A
  • Revenue Next Year
  • XRTX N/A
  • IVP N/A
  • P/E Ratio
  • XRTX N/A
  • IVP N/A
  • Revenue Growth
  • XRTX N/A
  • IVP 6.12
  • 52 Week Low
  • XRTX $0.82
  • IVP $2.00
  • 52 Week High
  • XRTX $7.00
  • IVP $401.50
  • Technical
  • Relative Strength Index (RSI)
  • XRTX 34.99
  • IVP 26.11
  • Support Level
  • XRTX $0.87
  • IVP $2.03
  • Resistance Level
  • XRTX $0.97
  • IVP $2.20
  • Average True Range (ATR)
  • XRTX 0.07
  • IVP 0.19
  • MACD
  • XRTX 0.00
  • IVP 0.07
  • Stochastic Oscillator
  • XRTX 0.00
  • IVP 11.19

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

About IVP Inspire Veterinary Partners Inc.

Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.

Share on Social Networks: